Annexin-A1: Therapeutic potential in microvascular disease
Annexin-A1 (ANXA1) was first discovered in the early 1980's as a protein, which mediates (some of the) anti-inflammatory effects of glucocorticoids. Subsequently, the role of ANXA1 in inflammation has been extensively studied. The biology of ANXA1 is complex and it has many different roles in b...
Главные авторы: | Purvis, G, Solito, E, Thiemermann, C |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Frontiers Media
2019
|
Схожие документы
-
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
по: Purvis, G, и др.
Опубликовано: (2017) -
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
по: Zhibin Yan, и др.
Опубликовано: (2022-11-01) -
Annexin 1 and the regulation of endocrine function.
по: John, C, и др.
Опубликовано: (2004) -
Annexin A1 in the brain--undiscovered roles?
по: Solito, E, и др.
Опубликовано: (2008) -
Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.
по: Buckingham, J, и др.
Опубликовано: (2006)